From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
Open Access
- 21 July 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 133 (19), 2271-2273
- https://doi.org/10.1097/cm9.0000000000000981
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 18 references indexed in Scilit:
- Toward More Accurate Nomenclature for Fatty Liver DiseasesGastroenterology, 2019
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2018
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030Journal of Hepatology, 2018
- New trends on obesity and NAFLD in AsiaJournal of Hepatology, 2017
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesJournal of Hepatology, 2017
- Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2017
- Renaming non-communicable diseasesThe Lancet. Global Health, 2017
- Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2017
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and EuropeJournal of Hepatology, 2016
- Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.1980